1 Study Coverage 1.1 Recombinant Human Interferon Product Introduction 1.2 Market by Type 1.2.1 Global Recombinant Human Interferon Market Size Growth Rate by Type 1.2.2 Gamma Inhibitors 1.2.3 Alpha Inhibitors 1.2.4 Others 1.3 Market by Application 1.3.1 Global Recombinant Human Interferon Market Size Growth Rate by Application 1.3.2 Hepatitis B 1.3.3 Hepatitis C 1.3.4 Multiple Sclerosis 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Recombinant Human Interferon Market Size, Estimates and Forecasts 2.1.1 Global Recombinant Human Interferon Revenue 2016-2027 2.1.2 Global Recombinant Human Interferon Sales 2016-2027 2.2 Global Recombinant Human Interferon, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Recombinant Human Interferon Historical Market Size by Region (2016-2021) 2.3.1 Global Recombinant Human Interferon Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Recombinant Human Interferon Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Recombinant Human Interferon Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Recombinant Human Interferon Sales Forecast by Region (2022-2027) 2.4.2 Global Recombinant Human Interferon Revenue Forecast by Region (2022-2027) 3 Global Recombinant Human Interferon Competitor Landscape by Players 3.1 Global Top Recombinant Human Interferon Manufacturers by Sales 3.1.1 Global Recombinant Human Interferon Sales by Manufacturer (2016-2021) 3.1.2 Global Recombinant Human Interferon Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Recombinant Human Interferon Manufacturers by Revenue 3.2.1 Key Recombinant Human Interferon Manufacturers Covered: Ranking by Revenue 3.2.2 Global Recombinant Human Interferon Revenue by Manufacturers (2016-2021) 3.2.3 Global Recombinant Human Interferon Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Recombinant Human Interferon Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Recombinant Human Interferon Revenue in 2020 3.2.6 Global Recombinant Human Interferon Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Recombinant Human Interferon Price by Manufacturers 3.4 Global Recombinant Human Interferon Manufacturing Base Distribution, Product Types 3.4.1 Recombinant Human Interferon Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Recombinant Human Interferon Product Type 3.4.3 Date of International Manufacturers Enter into Recombinant Human Interferon Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Recombinant Human Interferon Market Size by Type (2016-2021) 4.1.1 Global Recombinant Human Interferon Sales by Type (2016-2021) 4.1.2 Global Recombinant Human Interferon Revenue by Type (2016-2021) 4.1.3 Recombinant Human Interferon Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Recombinant Human Interferon Market Size Forecast by Type (2022-2027) 4.2.1 Global Recombinant Human Interferon Sales Forecast by Type (2022-2027) 4.2.2 Global Recombinant Human Interferon Revenue Forecast by Type (2022-2027) 4.2.3 Recombinant Human Interferon Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Recombinant Human Interferon Market Size by Application (2016-2021) 5.1.1 Global Recombinant Human Interferon Sales by Application (2016-2021) 5.1.2 Global Recombinant Human Interferon Revenue by Application (2016-2021) 5.1.3 Recombinant Human Interferon Price by Application (2016-2021) 5.2 Recombinant Human Interferon Market Size Forecast by Application (2022-2027) 5.2.1 Global Recombinant Human Interferon Sales Forecast by Application (2022-2027) 5.2.2 Global Recombinant Human Interferon Revenue Forecast by Application (2022-2027) 5.2.3 Global Recombinant Human Interferon Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States Recombinant Human Interferon Market Size YoY Growth 2016-2027 6.1.1 United States Recombinant Human Interferon Sales YoY Growth 2016-2027 6.1.2 United States Recombinant Human Interferon Revenue YoY Growth 2016-2027 6.1.3 United States Recombinant Human Interferon Market Share in Global Market 2016-2027 6.2 United States Recombinant Human Interferon Market Size by Players (International and Local Players) 6.2.1 United States Top Recombinant Human Interferon Players by Sales (2016-2021) 6.2.2 United States Top Recombinant Human Interferon Players by Revenue (2016-2021) 6.3 United States Recombinant Human Interferon Historic Market Review by Type (2016-2021) 6.3.1 United States Recombinant Human Interferon Sales Market Share by Type (2016-2021) 6.3.2 United States Recombinant Human Interferon Revenue Market Share by Type (2016-2021) 6.3.3 United States Recombinant Human Interferon Price by Type (2016-2021) 6.4 United States Recombinant Human Interferon Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States Recombinant Human Interferon Sales Forecast by Type (2022-2027) 6.4.2 United States Recombinant Human Interferon Revenue Forecast by Type (2022-2027) 6.4.3 United States Recombinant Human Interferon Price Forecast by Type (2022-2027) 6.5 United States Recombinant Human Interferon Historic Market Review by Application (2016-2021) 6.5.1 United States Recombinant Human Interferon Sales Market Share by Application (2016-2021) 6.5.2 United States Recombinant Human Interferon Revenue Market Share by Application (2016-2021) 6.5.3 United States Recombinant Human Interferon Price by Application (2016-2021) 6.6 United States Recombinant Human Interferon Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States Recombinant Human Interferon Sales Forecast by Application (2022-2027) 6.6.2 United States Recombinant Human Interferon Revenue Forecast by Application (2022-2027) 6.6.3 United States Recombinant Human Interferon Price Forecast by Application (2022-2027) 7 North America 7.1 North America Recombinant Human Interferon Market Size YoY Growth 2016-2027 7.2 North America Recombinant Human Interferon Market Facts & Figures by Country 7.2.1 North America Recombinant Human Interferon Sales by Country (2016-2021) 7.2.2 North America Recombinant Human Interferon Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Recombinant Human Interferon Market Size YoY Growth 2016-2027 8.2 Asia Pacific Recombinant Human Interferon Market Facts & Figures by Region 8.2.1 Asia Pacific Recombinant Human Interferon Sales by Region (2016-2021) 8.2.2 Asia Pacific Recombinant Human Interferon Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Recombinant Human Interferon Market Size YoY Growth 2016-2027 9.2 Europe Recombinant Human Interferon Market Facts & Figures by Country 9.2.1 Europe Recombinant Human Interferon Sales by Country (2016-2021) 9.2.2 Europe Recombinant Human Interferon Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Recombinant Human Interferon Market Size YoY Growth 2016-2027 10.2 Latin America Recombinant Human Interferon Market Facts & Figures by Country 10.2.1 Latin America Recombinant Human Interferon Sales by Country (2016-2021) 10.2.2 Latin America Recombinant Human Interferon Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Recombinant Human Interferon Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Recombinant Human Interferon Market Facts & Figures by Country 11.2.1 Middle East and Africa Recombinant Human Interferon Sales by Country (2016-2021) 11.2.2 Middle East and Africa Recombinant Human Interferon Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Roche 12.1.1 Roche Corporation Information 12.1.2 Roche Description and Business Overview 12.1.3 Roche Recombinant Human Interferon Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Roche Recombinant Human Interferon Products Offered 12.1.5 Roche Recent Development 12.2 Merck 12.2.1 Merck Corporation Information 12.2.2 Merck Description and Business Overview 12.2.3 Merck Recombinant Human Interferon Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Merck Recombinant Human Interferon Products Offered 12.2.5 Merck Recent Development 12.3 Bayer 12.3.1 Bayer Corporation Information 12.3.2 Bayer Description and Business Overview 12.3.3 Bayer Recombinant Human Interferon Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Bayer Recombinant Human Interferon Products Offered 12.3.5 Bayer Recent Development 12.4 Biogen Idec 12.4.1 Biogen Idec Corporation Information 12.4.2 Biogen Idec Description and Business Overview 12.4.3 Biogen Idec Recombinant Human Interferon Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Biogen Idec Recombinant Human Interferon Products Offered 12.4.5 Biogen Idec Recent Development 12.5 Gensci 12.5.1 Gensci Corporation Information 12.5.2 Gensci Description and Business Overview 12.5.3 Gensci Recombinant Human Interferon Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Gensci Recombinant Human Interferon Products Offered 12.5.5 Gensci Recent Development 12.6 Huaxin 12.6.1 Huaxin Corporation Information 12.6.2 Huaxin Description and Business Overview 12.6.3 Huaxin Recombinant Human Interferon Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Huaxin Recombinant Human Interferon Products Offered 12.6.5 Huaxin Recent Development 12.7 Triprime 12.7.1 Triprime Corporation Information 12.7.2 Triprime Description and Business Overview 12.7.3 Triprime Recombinant Human Interferon Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Triprime Recombinant Human Interferon Products Offered 12.7.5 Triprime Recent Development 12.8 Sinovac 12.8.1 Sinovac Corporation Information 12.8.2 Sinovac Description and Business Overview 12.8.3 Sinovac Recombinant Human Interferon Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Sinovac Recombinant Human Interferon Products Offered 12.8.5 Sinovac Recent Development 12.9 Zhaoke 12.9.1 Zhaoke Corporation Information 12.9.2 Zhaoke Description and Business Overview 12.9.3 Zhaoke Recombinant Human Interferon Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Zhaoke Recombinant Human Interferon Products Offered 12.9.5 Zhaoke Recent Development 12.10 Kawin 12.10.1 Kawin Corporation Information 12.10.2 Kawin Description and Business Overview 12.10.3 Kawin Recombinant Human Interferon Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Kawin Recombinant Human Interferon Products Offered 12.10.5 Kawin Recent Development 12.11 Roche 12.11.1 Roche Corporation Information 12.11.2 Roche Description and Business Overview 12.11.3 Roche Recombinant Human Interferon Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Roche Recombinant Human Interferon Products Offered 12.11.5 Roche Recent Development 12.12 R&D Systems 12.12.1 R&D Systems Corporation Information 12.12.2 R&D Systems Description and Business Overview 12.12.3 R&D Systems Recombinant Human Interferon Sales, Revenue and Gross Margin (2016-2021) 12.12.4 R&D Systems Products Offered 12.12.5 R&D Systems Recent Development 12.13 Thermo Fisher Scientific 12.13.1 Thermo Fisher Scientific Corporation Information 12.13.2 Thermo Fisher Scientific Description and Business Overview 12.13.3 Thermo Fisher Scientific Recombinant Human Interferon Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Thermo Fisher Scientific Products Offered 12.13.5 Thermo Fisher Scientific Recent Development 12.14 BioLegend 12.14.1 BioLegend Corporation Information 12.14.2 BioLegend Description and Business Overview 12.14.3 BioLegend Recombinant Human Interferon Sales, Revenue and Gross Margin (2016-2021) 12.14.4 BioLegend Products Offered 12.14.5 BioLegend Recent Development 12.15 Invitrogen 12.15.1 Invitrogen Corporation Information 12.15.2 Invitrogen Description and Business Overview 12.15.3 Invitrogen Recombinant Human Interferon Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Invitrogen Products Offered 12.15.5 Invitrogen Recent Development 12.16 OriGene 12.16.1 OriGene Corporation Information 12.16.2 OriGene Description and Business Overview 12.16.3 OriGene Recombinant Human Interferon Sales, Revenue and Gross Margin (2016-2021) 12.16.4 OriGene Products Offered 12.16.5 OriGene Recent Development 12.17 Biorbyt 12.17.1 Biorbyt Corporation Information 12.17.2 Biorbyt Description and Business Overview 12.17.3 Biorbyt Recombinant Human Interferon Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Biorbyt Products Offered 12.17.5 Biorbyt Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Recombinant Human Interferon Industry Trends 13.2 Recombinant Human Interferon Market Drivers 13.3 Recombinant Human Interferon Market Challenges 13.4 Recombinant Human Interferon Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Recombinant Human Interferon Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Recombinant Human Interferon Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Gamma Inhibitors Table 3. Major Manufacturers of Alpha Inhibitors Table 4. Major Manufacturers of Others Table 5. Global Recombinant Human Interferon Market Size Growth Rate by Application (2021-2027) & (KG) Table 6. Global Recombinant Human Interferon Market Size by Region (KG) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Recombinant Human Interferon Sales by Regions (2016-2021) & (KG) Table 8. Global Recombinant Human Interferon Sales Market Share by Regions (2016-2021) Table 9. Global Recombinant Human Interferon Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Recombinant Human Interferon Sales Forecast by Region (2022-2027) & (KG) Table 11. Global Recombinant Human Interferon Sales Market Share Forecast by Region (2022-2027) Table 12. Global Recombinant Human Interferon Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Recombinant Human Interferon Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Recombinant Human Interferon Sales by Manufacturers (2016-2021) (KG) Table 15. Global Recombinant Human Interferon Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Recombinant Human Interferon Manufacturers by Revenue (US$ Million) in 2020 Table 17. Recombinant Human Interferon Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Recombinant Human Interferon Revenue Share by Manufacturers (2016-2021) Table 19. Global Recombinant Human Interferon Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Recombinant Human Interferon by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human Interferon as of 2020) Table 21. Key Manufacturers Recombinant Human Interferon Price (2016-2021) (USD/g) Table 22. Recombinant Human Interferon Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Recombinant Human Interferon Product Type Table 24. Date of International Manufacturers Enter into Recombinant Human Interferon Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Recombinant Human Interferon Sales by Type (2016-2021) (KG) Table 27. Global Recombinant Human Interferon Sales Share by Type (2016-2021) Table 28. Global Recombinant Human Interferon Revenue by Type (2016-2021) (US$ Million) Table 29. Global Recombinant Human Interferon Revenue Share by Type (2016-2021) Table 30. Recombinant Human Interferon Average Selling Price (ASP) by Type (2016-2021) & (USD/g) Table 31. Global Recombinant Human Interferon Sales Forecast by Type (2022-2027) & (KG) Table 32. Global Recombinant Human Interferon Sales Market Share Forecast by Type (2022-2027) Table 33. Global Recombinant Human Interferon Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Recombinant Human Interferon Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Recombinant Human Interferon Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/g) Table 36. Global Recombinant Human Interferon Sales by Application (2016-2021) (KG) Table 37. Global Recombinant Human Interferon Sales Share by Application (2016-2021) Table 38. Global Recombinant Human Interferon Revenue by Application (2016-2021) (US$ Million) Table 39. Global Recombinant Human Interferon Revenue Share by Application (2016-2021) Table 40. Recombinant Human Interferon Average Selling Price (ASP) by Application (2016-2021) & (USD/g) Table 41. Global Recombinant Human Interferon Sales Forecast by Application (2022-2027) & (KG) Table 42. Global Recombinant Human Interferon Sales Market Share Forecast by Application (2022-2027) Table 43. Global Recombinant Human Interferon Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Recombinant Human Interferon Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Recombinant Human Interferon Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/g) Table 46. United States Recombinant Human Interferon Sales (KG) of Key Companies (2016-2021) Table 47. United States Recombinant Human Interferon Sales Share by Company (2016-2021) Table 48. United States Recombinant Human Interferon Revenue (US$ Million) by Company (2016-2021) Table 49. United States Recombinant Human Interferon Revenue Share by Company (2016-2021) Table 50. United States Recombinant Human Interferon Sales (KG) by Type (2016-2021) Table 51. United States Recombinant Human Interferon Sales Share by Type (2016-2021) Table 52. United States Recombinant Human Interferon Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. United States Recombinant Human Interferon Price (USD/g) by Type (2016-2021) Table 54. United States Recombinant Human Interferon Sales (KG) by Type (2022-2027) Table 55. United States Recombinant Human Interferon Sales Share by Type (2022-2027) Table 56. United States Recombinant Human Interferon Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. United States Recombinant Human Interferon Revenue Share by Type (2022-2027) Table 58. United States Recombinant Human Interferon Price (USD/g) by Type (2022-2027) Table 59. United States Recombinant Human Interferon Sales (KG) by Application (2016-2021) Table 60. United States Recombinant Human Interferon Sales Share by Application (2016-2021) Table 61. United States Recombinant Human Interferon Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. United States Recombinant Human Interferon Price (USD/g) by Application (2016-2021) Table 63. United States Recombinant Human Interferon Sales (KG) by Application (2022-2027) Table 64. United States Recombinant Human Interferon Sales Share by Application (2022-2027) Table 65. United States Recombinant Human Interferon Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. United States Recombinant Human Interferon Revenue Share by Application (2022-2027) Table 67. United States Recombinant Human Interferon Price (USD/g) by Application (2022-2027) Table 68. North America Recombinant Human Interferon Sales by Country (2016-2021) & (KG) Table 69. North America Recombinant Human Interferon Sales Market Share by Country (2016-2021) Table 70. North America Recombinant Human Interferon Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Recombinant Human Interferon Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Recombinant Human Interferon Sales by Region (2016-2021) & (KG) Table 73. Asia Pacific Recombinant Human Interferon Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Recombinant Human Interferon Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Recombinant Human Interferon Revenue Market Share by Region (2016-2021) Table 76. Europe Recombinant Human Interferon Sales by Country (2016-2021) & (KG) Table 77. Europe Recombinant Human Interferon Sales Market Share by Country (2016-2021) Table 78. Europe Recombinant Human Interferon Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Recombinant Human Interferon Revenue Market Share by Country (2016-2021) Table 80. Latin America Recombinant Human Interferon Sales by Country (2016-2021) & (KG) Table 81. Latin America Recombinant Human Interferon Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Recombinant Human Interferon Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Recombinant Human Interferon Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Recombinant Human Interferon Sales by Country (2016-2021) & (KG) Table 85. Middle East and Africa Recombinant Human Interferon Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Recombinant Human Interferon Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Recombinant Human Interferon Revenue Market Share by Country (2016-2021) Table 88. Roche Corporation Information Table 89. Roche Description and Business Overview Table 90. Roche Recombinant Human Interferon Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 91. Roche Recombinant Human Interferon Product Table 92. Roche Recent Development Table 93. Merck Corporation Information Table 94. Merck Description and Business Overview Table 95. Merck Recombinant Human Interferon Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 96. Merck Product Table 97. Merck Recent Development Table 98. Bayer Corporation Information Table 99. Bayer Description and Business Overview Table 100. Bayer Recombinant Human Interferon Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 101. Bayer Product Table 102. Bayer Recent Development Table 103. Biogen Idec Corporation Information Table 104. Biogen Idec Description and Business Overview Table 105. Biogen Idec Recombinant Human Interferon Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 106. Biogen Idec Product Table 107. Biogen Idec Recent Development Table 108. Gensci Corporation Information Table 109. Gensci Description and Business Overview Table 110. Gensci Recombinant Human Interferon Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 111. Gensci Product Table 112. Gensci Recent Development Table 113. Huaxin Corporation Information Table 114. Huaxin Description and Business Overview Table 115. Huaxin Recombinant Human Interferon Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 116. Huaxin Product Table 117. Huaxin Recent Development Table 118. Triprime Corporation Information Table 119. Triprime Description and Business Overview Table 120. Triprime Recombinant Human Interferon Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 121. Triprime Product Table 122. Triprime Recent Development Table 123. Sinovac Corporation Information Table 124. Sinovac Description and Business Overview Table 125. Sinovac Recombinant Human Interferon Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 126. Sinovac Product Table 127. Sinovac Recent Development Table 128. Zhaoke Corporation Information Table 129. Zhaoke Description and Business Overview Table 130. Zhaoke Recombinant Human Interferon Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 131. Zhaoke Product Table 132. Zhaoke Recent Development Table 133. Kawin Corporation Information Table 134. Kawin Description and Business Overview Table 135. Kawin Recombinant Human Interferon Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 136. Kawin Product Table 137. Kawin Recent Development Table 138. Abcam plc Corporation Information Table 139. Abcam plc Description and Business Overview Table 140. Abcam plc Recombinant Human Interferon Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 141. Abcam plc Product Table 142. Abcam plc Recent Development Table 143. R&D Systems Corporation Information Table 144. R&D Systems Description and Business Overview Table 145. R&D Systems Recombinant Human Interferon Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 146. R&D Systems Product Table 147. R&D Systems Recent Development Table 148. Thermo Fisher Scientific Corporation Information Table 149. Thermo Fisher Scientific Description and Business Overview Table 150. Thermo Fisher Scientific Recombinant Human Interferon Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 151. Thermo Fisher Scientific Product Table 152. Thermo Fisher Scientific Recent Development Table 153. BioLegend Corporation Information Table 154. BioLegend Description and Business Overview Table 155. BioLegend Recombinant Human Interferon Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 156. BioLegend Product Table 157. BioLegend Recent Development Table 158. Invitrogen Corporation Information Table 159. Invitrogen Description and Business Overview Table 160. Invitrogen Recombinant Human Interferon Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 161. Invitrogen Product Table 162. Invitrogen Recent Development Table 163. OriGene Corporation Information Table 164. OriGene Description and Business Overview Table 165. OriGene Recombinant Human Interferon Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 166. OriGene Product Table 167. OriGene Recent Development Table 168. Biorbyt Corporation Information Table 169. Biorbyt Description and Business Overview Table 170. Biorbyt Recombinant Human Interferon Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2016-2021) Table 171. Biorbyt Product Table 172. Biorbyt Recent Development Table 173. Recombinant Human Interferon Market Trends Table 174. Recombinant Human Interferon Market Drivers Table 175. Recombinant Human Interferon Market Challenges Table 176. Recombinant Human Interferon Market Restraints Table 177. Recombinant Human Interferon Customers List Table 178. Recombinant Human Interferon Distributors List Table 179. Research Programs/Design for This Report Table 180. Key Data Information from Secondary Sources Table 181. Key Data Information from Primary Sources List of Figures Figure 1. Recombinant Human Interferon Product Picture Figure 2. Global Recombinant Human Interferon Sales Market Share by Type in 2020 & 2027 Figure 3. Gamma Inhibitors Product Picture Figure 4. Alpha Inhibitors Product Picture Figure 5. Others Product Picture Figure 6. Global Recombinant Human Interferon Sales Market Share by Application in 2020 & 2027 Figure 7. Hepatitis B Figure 8. Hepatitis C Figure 9. Multiple Sclerosis Figure 10. Others Figure 11. Recombinant Human Interferon Report Years Considered Figure 12. Global Recombinant Human Interferon Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Recombinant Human Interferon Market Size 2016-2027 (US$ Million) Figure 14. Global Recombinant Human Interferon Sales 2016-2027 (KG) Figure 15. Global Recombinant Human Interferon Market Size Market Share by Region: 2021 Versus 2027 Figure 16. Global Recombinant Human Interferon Sales Market Share by Region (2016-2021) Figure 17. Global Recombinant Human Interferon Sales Market Share by Region in 2020 Figure 18. Global Recombinant Human Interferon Revenue Market Share by Region (2016-2021) Figure 19. Global Recombinant Human Interferon Revenue Market Share by Region in 2020 Figure 20. Global Recombinant Human Interferon Sales Share by Manufacturer in 2020 Figure 21. The Top 10 and 5 Players Market Share by Recombinant Human Interferon Revenue in 2020 Figure 22. Recombinant Human Interferon Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Recombinant Human Interferon Sales Market Share by Type (2016-2021) Figure 24. Global Recombinant Human Interferon Sales Market Share by Type in 2020 Figure 25. Global Recombinant Human Interferon Revenue Market Share by Type (2016-2021) Figure 26. Global Recombinant Human Interferon Revenue Market Share by Type in 2020 Figure 27. Global Recombinant Human Interferon Sales Market Share by Application (2016-2021) Figure 28. Global Recombinant Human Interferon Sales Market Share by Application in 2020 Figure 29. Global Recombinant Human Interferon Revenue Market Share by Application (2016-2021) Figure 30. Global Recombinant Human Interferon Revenue Market Share by Application in 2020 Figure 31. United States Recombinant Human Interferon Sales Growth Rate 2016-2027 (KG) Figure 32. United States Recombinant Human Interferon Revenue Growth Rate 2016-2027 (US$ Million) Figure 33. United States Recombinant Human Interferon Market Share in Global Market 2016-2027 Figure 34. United States 5 and 10 Largest Recombinant Human Interferon Players Market Share by Revenue in Recombinant Human Interferon in 2020 Figure 35. United States Recombinant Human Interferon Revenue Share by Type (2016-2021) Figure 36. United States Recombinant Human Interferon Revenue Growth Rate by Type in 2016 & 2020 Figure 37. United States Recombinant Human Interferon Revenue Share by Application (2016-2021) Figure 38. United States Recombinant Human Interferon Revenue Growth Rate by Application in 2016 & 2020 Figure 39. North America Recombinant Human Interferon Sales Growth Rate 2016-2021 (KG) Figure 40. North America Recombinant Human Interferon Revenue Growth Rate 2016-2021 (US$ Million) Figure 41. North America Recombinant Human Interferon Sales Market Share by Country in 2020 Figure 42. North America Recombinant Human Interferon Revenue Market Share by Country in 2020 Figure 43. U.S. Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 44. U.S. Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Canada Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 46. Canada Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Europe Recombinant Human Interferon Sales Growth Rate 2016-2021 (KG) Figure 48. Europe Recombinant Human Interferon Revenue Growth Rate 2016-2021 (US$ Million) Figure 49. Europe Recombinant Human Interferon Sales Market Share by Country in 2020 Figure 50. Europe Recombinant Human Interferon Revenue Market Share by Country in 2020 Figure 51. Germany Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 52. Germany Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. France Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 54. France Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. U.K. Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 56. U.K. Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Italy Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 58. Italy Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Russia Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 60. Russia Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Asia Pacific Recombinant Human Interferon Sales Growth Rate 2016-2021 (KG) Figure 62. Asia Pacific Recombinant Human Interferon Revenue Growth Rate 2016-2021 (US$ Million) Figure 63. Asia Pacific Recombinant Human Interferon Sales Market Share by Region in 2020 Figure 64. Asia Pacific Recombinant Human Interferon Revenue Market Share by Region in 2020 Figure 65. China Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 66. China Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. Japan Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 68. Japan Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. South Korea Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 70. South Korea Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. India Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 72. India Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Australia Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 74. Australia Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Taiwan Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 76. Taiwan Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Indonesia Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 78. Indonesia Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Thailand Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 80. Thailand Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Malaysia Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 82. Malaysia Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Philippines Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 84. Philippines Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Vietnam Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 86. Vietnam Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Latin America Recombinant Human Interferon Sales Growth Rate 2016-2021 (KG) Figure 88. Latin America Recombinant Human Interferon Revenue Growth Rate 2016-2021 (US$ Million) Figure 89. Latin America Recombinant Human Interferon Sales Market Share by Country in 2020 Figure 90. Latin America Recombinant Human Interferon Revenue Market Share by Country in 2020 Figure 91. Mexico Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 92. Mexico Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Brazil Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 94. Brazil Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Argentina Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 96. Argentina Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. Middle East and Africa Recombinant Human Interferon Sales Growth Rate 2016-2021 (KG) Figure 98. Middle East and Africa Recombinant Human Interferon Revenue Growth Rate 2016-2021 (US$ Million) Figure 99. Middle East and Africa Recombinant Human Interferon Sales Market Share by Country in 2020 Figure 100. Middle East and Africa Recombinant Human Interferon Revenue Market Share by Country in 2020 Figure 101. Turkey Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 102. Turkey Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. Saudi Arabia Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 104. Saudi Arabia Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. U.A.E Recombinant Human Interferon Sales Growth Rate (2016-2021) (KG) Figure 106. U.A.E Recombinant Human Interferon Revenue Growth Rate (2016-2021) (US$ Million) Figure 107. Recombinant Human Interferon Value Chain Figure 108. Channels of Distribution Figure 109. Distributors Profiles Figure 110. Bottom-up and Top-down Approaches for This Report Figure 111. Data Triangulation Figure 112. Key Executives Interviewed

Roche Merck Bayer Biogen Idec Gensci Huaxin Triprime Sinovac Zhaoke Kawin Abcam plc R&D Systems Thermo Fisher Scientific BioLegend Invitrogen OriGene Biorbyt